Class II transactivator-induced MHC class II expression in pancreatic cancer cells leads to tumor rejection and a specific antitumor memory response.

Autor: Ekkirala CR; From the *Center for Experimental Research and Medical Studies, Città della Salute e della Scienza di Torino; and †Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino; ‡Department of Surgical and Morphological Sciences, University of Insubria, Varese, Italy; §UGC Laboratorio Clinico, Hospital Universitario Virgen de las Nieves; and ∥Department of Bioquımica, Biologia Molecular e Inmunologia III, Universidad de Granada, Granada, Spain., Cappello P, Accolla RS, Giovarelli M, Romero I, Garrido C, Garcia-Lora AM, Novelli F

Publikováno v: Pancreas [Pancreas] 2014 Oct; Vol. 43 (7), pp. 1066-72.